Relationship of plasma interleukin-6 and its genetic variants with hypertension in Hong Kong chinese

American Journal of Hypertension

Volumn 24, Issue 12, 2011, Pages 1331-1337

  Cheung, Bernard M Y ^a   Ong, Kwok Leung ^a,b   Tso, Annette W K ^a   Leung, Raymond Y H ^a   Cherny, Stacey S ^a,c   Sham, Pak Chung ^a,c   Thomas, G Neil ^d   Lam, Tai Hing ^a   Lam, Karen S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

blood pressure; hypertension; interleukin 6; single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HONG KONG; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HONG KONG; HUMANS; HYPERTENSION; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SEX FACTORS;

EID: 81155159688     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.141     Document Type: Article

References (40)

1. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24:278-301. (Pubitemid 36724371)
2. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56:1010-1013. (Pubitemid 46525079)
3. Castell JV, Gómez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242:237-239. (Pubitemid 19020112)
4. Ong KL, Tso AW, Cherny SS, Sham PC, Lam KS, Jiang CQ, Thomas GN, Lam TH, Cheung BM. A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men. Thromb Haemost 2010; 103:728-735.
5. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290:2945-2951. (Pubitemid 37505526)
6. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38:399-403. (Pubitemid 34225673)
7. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002; 105:1890-1896. (Pubitemid 34437614)
8. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB; Framingham Heart Study. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003; 107:1486-1491. (Pubitemid 36378485)
9. Virdis A, Ghiadoni L, Plantinga Y, Taddei S, Salvetti A. C-reactive protein and hypertension: is there a causal relationship? Curr Pharm Des 2007; 13:1693-1698. (Pubitemid 46979723)
10. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000; 101:1372-1378. (Pubitemid 30169857)
11. Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension 2007; 49:304-310. (Pubitemid 46150768)
12. Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens 2011; 25:73-79.
13. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22:2243-2252. (Pubitemid 34000979)
14. Tanaka C, Mannami T, Kamide K, Takiuchi S, Kokubo Y, Katsuya T, Kawano Y, Miyata T, Ogihara T, Tomoike H. Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in a Japanese general population. Hypertens Res 2005; 28:35-41. (Pubitemid 40584961)
15. Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999; 1:115-119. (Pubitemid 129627288)
16. Wong LY, Leung RY, Ong KL, Cheung BM. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene-572C〉G polymorphism in subjects with and without hypertension. J Hum Hypertens 2007; 21:875-882. (Pubitemid 350027163)
17. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, Lam TH, Lam KS. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 2007; 30: 1430-1436. (Pubitemid 46871150)
18. Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, Lam KS. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J Hypertens 2008; 21:17-22.
19. Ong KL, Li M, Tso AW, Xu A, Cherny SS, Sham PC, Tse HF, Lam TH, Cheung BM, Lam KS; Investigators of the Hong Kong Cardiovascular Risk Factor Prevalence Study. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 2010; 163: 251-257.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265. (Pubitemid 40202029)
21. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19:149-150. (Pubitemid 36150192)
22. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-769. (Pubitemid 38420107)
23. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41:207-210. (Pubitemid 36204890)
24. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286:2107-2113. (Pubitemid 34041595)
25. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108:2317-2322. (Pubitemid 37413536)
26. Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 2008; 51:1142-1148. (Pubitemid 351398962)
27. Sunyer J, Forastiere F, Pekkanen J, Plana E, Kolz M, Pistelli R, Jacquemin B, Brüske-Hohlfeld I, Pitsavos Ch, Bellander T, Koenig W, Peters A; AIRGENE Study Group. Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res 2009; 11:1347-1353.
28. Asferg C, Jensen JS, Marott JL, Appleyard M, Møgelvang R, Jensen GB, Jeppesen J. Markers of inflammation and hemodynamic measurements in obesity: Copenhagen City Heart Study. Am J Hypertens 2009; 22:451-456.
29. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88: 255-259. (Pubitemid 36115175)
30. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-320. (Pubitemid 28067327)
31. Jiang CQ, Lam TH, Liu B, Lin JM, Yue XJ, Jin YL, Cheung BM, Thomas GN. Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. Obesity (Silver Spring) 2010; 18:1969-1974.
32. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene-174g〉c and-572g〉c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-1463. (Pubitemid 34219808)
33. Mälarstig A, Wallentin L, Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res 2007; 119:467-473. (Pubitemid 46149892)
34. Sanderson SC, Kumari M, Brunner EJ, Miller MA, Rumley A, Lowe GD, Marmot MG, Humphries SE. Association between IL6 gene variants-174G〉C and-572G〉C and serum IL6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis 2009; 204:459-464.
35. Koh SJ, Jang Y, Hyun YJ, Park JY, Song YD, Shin KK, Chae JS, Kim BK, Ordovas JM, Lee JH. Interleukin-6 (IL6)-572C-〉G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Clin Endocrinol (Oxf ) 2009; 70:238-244.
36. Conen D, Cheng S, Steiner LL, Buring JE, Ridker PM, Zee RY. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. J Hypertens 2009; 27:476-483.
37. Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, Langer B, Thorand B, Klopp N, Hamid YH, Pedersen O, Hansen T, Lyssenko V, Groop L, Meisinger C, Döring A, Löwel H, Lieb W, Hengstenberg C, Rathmann W, Martin S, Stephens JW, Ireland H, Mather H, Miller GJ, Stringham HM, Boehnke M, Tuomilehto J, Boeing H, Möhlig M, Spranger J, Pfeiffer A, Wernstedt I, Niklason A, López-Bermejo A, Fernández-Real JM, Hanson RL, Gallart L, Vendrell J, Tsiavou A, Hatziagelaki E, Humphries SE, Wichmann HE, Herder C, Illig T. IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes 2006; 55:2915-2921. (Pubitemid 44923696)
38. Tong Y, Wang Z, Geng Y, Liu J, Zhang R, Lin Q, Li X, Huang D, Gao S, Hu D, Li Y, Cheng J, Lu Z. The association of functional polymorphisms of IL6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem Biophys Res Commun 2010; 391:481-485.
39. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. Interleukin-6-174G〉C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 2002; 22:599-604. (Pubitemid 34408740)
40. Delles C, McBride MW, Graham D, Padmanabhan S, Dominiczak AF. Genetics of hypertension: from experimental animals to humans. Biochim Biophys Acta 2010; 1802:1299-1308.